Insys Founder Says 'Spillover Prejudice' Warrants New Trial
The founder of opioid maker Insys Therapeutics insisted Tuesday he deserves a new trial on his landmark racketeering conviction, telling a federal appeals court the outcome was adulterated by "spillover prejudice"...To view the full article, register now.
Already a subscriber? Click here to view full article